Company / Revenue per Share
Phathom Pharmaceuticals, Inc. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$2.56
FY2025
5-year range
$0.00 / $2.56
FY2022-FY2025
Trend
+21623.2%
vs FY2024
Sector context
#81 of 154
Health Care
What the data says
Revenue per Share changed +21623% YoY in FY2025, a notable deviation from the 2-year average annual change of +10797%.
Based on SEC 10-K filings.
2.56 in FY2025.
Improved from $0.02 to $2.56 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 154 in Health CareTop 53% of 154This company $2.56 Sector average $10.35
▼
-75.3% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 21623.2% year-over-year.
- Ranks #81 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.56 | +21623.2% |
| FY2024 | $0.01 | -28.5% |
| FY2023 | $0.02 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026